An endogenous, orally bioavailable small molecule in development for chronic liver disease and acute organ injury.
An investigational once-daily formulation of the widely-prescribed ADHD medication methylphenidate under evaluation for resistance to common methods of tampering.
An investigational non-opioid, locally-acting analgesic being evaluated for its ability to deliver 3 days of continuous pain relief after surgery.
An investigational long-acting injectable HIV product incorporating DURECT’s SABER® depot technology. Under development with Gilead Sciences, Inc.
© 2000-2020 DURECT Corporation
DURECT manufactures ALZET® osmotic pumps and LACTEL® absorbable polymers.